Aquilo Capital Management as of Sept. 30, 2023
Portfolio Holdings for Aquilo Capital Management
Aquilo Capital Management holds 12 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arrowhead Pharmaceuticals (ARWR) | 22.1 | $24M | 909k | 26.87 | |
| Blueprint Medicines (BPMC) | 17.3 | $19M | 379k | 50.22 | |
| Regenxbio Inc equity us cm (RGNX) | 12.6 | $14M | 847k | 16.46 | |
| Silence Therapeutics Ads (SLN) | 11.7 | $13M | 1.3M | 9.82 | |
| Kymera Therapeutics (KYMR) | 9.9 | $11M | 782k | 13.90 | |
| Merus N V (MRUS) | 9.2 | $10M | 430k | 23.58 | |
| Arvinas Ord (ARVN) | 8.7 | $9.6M | 489k | 19.64 | |
| C4 Therapeutics Com Stk (CCCC) | 3.4 | $3.7M | 2.0M | 1.86 | |
| Genmab A/s Sponsored Ads (GMAB) | 1.7 | $1.8M | 52k | 35.27 | |
| Argenx Se Sponsored Adr (ARGX) | 1.7 | $1.8M | 3.7k | 491.63 | |
| Olema Pharmaceuticals (OLMA) | 1.0 | $1.1M | 89k | 12.35 | |
| Pieris Pharmaceuticals | 0.9 | $984k | 3.3M | 0.30 |
